Life Cycle Investment Partners »

Alnylam Pharmaceuticals shares owned by Life Cycle Investment Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Life Cycle Investment Partners from 13F filings

Historical chart of Life Cycle Investment Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Life Cycle Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Life Cycle Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $59M 178k 330.87

More positions owned by Life Cycle Investment Partners

NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Taiwan Semiconductor Manufacturing Adr (TSM)
Steel Dynamics (STLD)
Facebook Inc cl a (META)
Visa (V)
Delta Air Lines (DAL)
Broadcom (AVGO)
Hca Holdings (HCA)
Cme (CME)
Progressive Corporation (PGR)
Valero Energy Corporation (VLO)

View all positions for Life Cycle Investment Partners

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Wellington Management Company
Dodge & Cox
American Century Companies
T. Rowe Price Investment Management

View all funds holding Alnylam Pharmaceuticals